Melbourne–Parkville Growth Precinct — Biomedical & Vaccines

Australia's biomedical heart: plasma, vaccines and the mRNA surge capacity a pandemic demands — the shield half of sovereign medicines. A later-stage addition, not yet costed.

This page is part of Growing Australia. A fully-costed $190.1B sovereign industry and cost-of-living plan: five programs across 26 Growth Precincts.

Five sovereign industry pillars

26 Growth Precincts

The plan, the methodology, and how it's funded

Take action

You are seeing this fallback because your browser has JavaScript disabled. The full interactive site requires JavaScript.